Innovative drug out-licensing deal value (half year)
China · as of 30 Jun 2026
Innovative drug out-licensing deal value in China (half year) stood at 100 billion USD as of 30 June 2026 (State Council).
- Publisher
- State Council
- Authority tier
- T1 Official
- Locator
- China to expand health insurance coverage for innovative drugs
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
In the first half of 2026, the total value of China's innovative drug out-licensing deals reached a record high of more than 100 billion U.S. dollars, according to the Ministry of Industry and Information Technology.
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Other sources disagree
1 record reports a different value for this same indicator, region and period. We keep both rather than choosing or averaging. The disagreement is itself information.
| Value | Divergence | Source organisation | Document | Locator | Details |
|---|---|---|---|---|---|
| 110 billion USD | +10.0% | NHSA | 国家医疗保障局 医保动态 我国上半年创新药对外授权交易额超千亿美元 | 我国上半年创新药对外授权约1100亿美元 创历史新高 | Open record |
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- State Council of China. (2026). China to expand health insurance coverage for innovative drugs. Retrieved September 17, 2026, from https://english.www.gov.cn/news/202609/04/content_WS6a9a7481c6d00ca5f9a0d02f.html. Via StatOrigin, https://statorigin.org/stat/stat_PZ26BJ8VTRJ1VBH8PDXM6YTAHF
- MLA
- State Council of China. "China to expand health insurance coverage for innovative drugs." 2026, https://english.www.gov.cn/news/202609/04/content_WS6a9a7481c6d00ca5f9a0d02f.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_PZ26BJ8VTRJ1VBH8PDXM6YTAHF.
- Chicago
- State Council of China. "China to expand health insurance coverage for innovative drugs." 2026. https://english.www.gov.cn/news/202609/04/content_WS6a9a7481c6d00ca5f9a0d02f.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_PZ26BJ8VTRJ1VBH8PDXM6YTAHF.
- BibTeX
- @misc{statecouncil2026innovative6ytahf, author = {{State Council of China}}, title = {China to expand health insurance coverage for innovative drugs}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_PZ26BJ8VTRJ1VBH8PDXM6YTAHF}, note = {Original source: https://english.www.gov.cn/news/202609/04/content\_WS6a9a7481c6d00ca5f9a0d02f.html. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary Source
- Publisher
- State Council of China · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- China to expand health insurance coverage for innovative drugs
- Type
- Press release
- Published
- —
- Locator
- China to expand health insurance coverage for innovative drugs
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_PZ26BJ8VTRJ1VBH8PDXM6YTAHF